Skip to content

The rise of new psychoactive substance use in Australia.

Lucy Burns, Amanda Roxburgh, Allison J Matthews, Raimondo Bruno, Simon Lenton, Joe Van Buskirk

Drug Testing and Analysis 2014 DOI: 10.1002/dta.1626 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 654
Population Regular ecstasy users in Australian capital cities, aged 16 or older, who had used ecstasy at least six times in the previous six months
Topics MDMA
Keywords New psychoactive substances Prevalence Nps Australia
Citations 78
Key findings 44% of regular ecstasy users had used an NPS in the past six months, with hallucinogenic NPS like 2C-I and 2C-B being most common.

Abstract

New Psychoactive Substances are now a feature of Australia's recreational drug market. Little is known, however, about the prevalence of use, the characteristics of people who use them and the relationship between the NPS and ecstasy markets. This study examined the prevalence and correlates of NPS use amongst a group of regular ecstasy users in Australia. Participants were recruited if they had used ecstasy at least six times in the previous six months, lived in a capital city and were over 16 years of age. Purposive sampling was used, recruiting through universities and colleges, word of mouth and street press. 654 participants were recruited in 2013. Respondents who had used an NPS in the past six months were compared to those who had not. NPS were used by 44% of the total sample. In 2013 2C-I (14%) and 2C-B (8%) were the most prevalent NPS. Respondents in the NPS group were younger and reported more frequent use of more types of drugs. They were also more likely to rate the purity of ecstasy as low relative to those in the no NPS group. NPS are now an established part of Australia's recreational drug scene and NPS with hallucinogenic effects are now used most commonly. Monitoring systems need to develop capacity to monitor this highly dynamic market.

Explore topics